C-Raf ablation completely prevented Kras-driven NSCLC without inducing deleterious effects, which, however, was not the case with B-Raf ablation, indicating that B-Raf is dispensable for Kras oncogenic signaling. Here, KRAS is linked to non-small cell lung carcinoma.